Basel Medical Group Ltd (BMGL)
NASDAQ: BMGL · Real-Time Price · USD
4.900
+0.320 (6.99%)
Sep 11, 2026, 4:00 PM EDT - Market closed
Basel Medical Group Income Statement
Financials in millions SGD. Fiscal year is July - June.
Millions SGD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Revenue | 14.55 | 11.32 | 10.05 | 9.7 | 10.66 |
Other Revenue | 0.18 | 0.04 | - | 0.05 | - |
| 14.74 | 11.35 | 10.05 | 9.75 | 10.66 | |
Revenue Growth | 47.34% | 12.97% | 3.12% | -8.55% | - |
Cost of Revenue | 12.67 | 8.95 | 5.89 | 5.58 | 2.72 |
Gross Profit | 2.06 | 2.4 | 4.16 | 4.16 | 7.94 |
Selling, General & Admin | 0.03 | 0.14 | 0 | 1.05 | 5.78 |
Other Operating Expenses | 3.49 | 3.22 | 1.44 | 0.55 | -0.31 |
Operating Expenses | 6.4 | 4.55 | 1.97 | 2.16 | 5.48 |
Operating Income | -4.34 | -2.14 | 2.2 | 2 | 2.46 |
Interest Expense | -0.32 | -0.2 | -0.18 | -0.24 | -0.32 |
Interest & Investment Income | 0.03 | 0.08 | - | 0.3 | 0.25 |
Other Non Operating Income (Expenses) | 2.63 | 1.56 | 0.39 | 0.07 | - |
EBT Excluding Unusual Items | -1.99 | -0.7 | 2.4 | 2.13 | 2.39 |
Impairment of Goodwill | -10.35 | -10.35 | - | - | - |
Pretax Income | -10.4 | -11.05 | 2.4 | 2.13 | 2.39 |
Income Tax Expense | -0.24 | -0.42 | 0.33 | 0.35 | 0.41 |
Earnings From Continuing Operations | -10.16 | -10.64 | 2.07 | 1.78 | 1.98 |
Minority Interest in Earnings | 0.11 | 0 | - | - | - |
Net Income | -10.05 | -10.64 | 2.07 | 1.78 | 1.98 |
Net Income to Common | -10.05 | -10.64 | 2.07 | 1.78 | 1.98 |
Net Income Growth | - | - | 16.23% | -9.84% | - |
Shares Outstanding (Basic) | 2 | 2 | 1 | 1 | 1 |
Shares Outstanding (Diluted) | 2 | 2 | 1 | 1 | 1 |
Shares Change | 23.41% | 15.60% | - | - | - |
EPS (Basic) | -6.01 | -6.79 | 1.53 | 1.32 | 1.46 |
EPS (Diluted) | -6.01 | -6.79 | 1.53 | 1.32 | 1.46 |
EPS Growth | - | - | 16.23% | -9.84% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -12.9 | -14.94 | 2.5 | 2.59 | 2.7 |
Free Cash Flow Per Share | -7.72 | -9.54 | 1.85 | 1.92 | 2.00 |
Gross Margin | 14.01% | 21.18% | 41.43% | 42.71% | 74.48% |
Operating Margin | -29.43% | -18.85% | 21.84% | 20.55% | 23.09% |
Profit Margin | -68.19% | -93.67% | 20.62% | 18.30% | 18.56% |
Free Cash Flow Margin | -87.52% | -131.58% | 24.89% | 26.61% | 25.37% |
EBITDA | -4.06 | -2.03 | 2.23 | 2.03 | 2.48 |
EBITDA Margin | -27.53% | -17.91% | 22.14% | 20.86% | 23.30% |
D&A For EBITDA | 0.28 | 0.11 | 0.03 | 0.03 | 0.02 |
EBIT | -4.34 | -2.14 | 2.2 | 2 | 2.46 |
EBIT Margin | -29.43% | -18.85% | 21.84% | 20.55% | 23.09% |
Effective Tax Rate | - | - | 13.80% | 16.34% | 17.12% |